- Home
- ACRV vs WGRX Comparison
ACRV vs WGRX Comparison
Compare ACRV & WGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- WGRX
- Stock Information
- Founded
- ACRV 2018
- WGRX 2022
- Country
- ACRV United States
- WGRX United States
- Employees
- ACRV N/A
- WGRX N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- WGRX Other Pharmaceuticals
- Sector
- ACRV Health Care
- WGRX Health Care
- Exchange
- ACRV Nasdaq
- WGRX Nasdaq
- Market Cap
- ACRV 47.8M
- WGRX 43.9M
- IPO Year
- ACRV 2022
- WGRX 2025
- Fundamental
- Price
- ACRV $1.89
- WGRX $0.64
- Analyst Decision
- ACRV Buy
- WGRX
- Analyst Count
- ACRV 6
- WGRX 0
- Target Price
- ACRV $17.75
- WGRX N/A
- AVG Volume (30 Days)
- ACRV 1.1M
- WGRX 42.0M
- Earning Date
- ACRV 11-07-2025
- WGRX 11-19-2025
- Dividend Yield
- ACRV N/A
- WGRX N/A
- EPS Growth
- ACRV N/A
- WGRX N/A
- EPS
- ACRV N/A
- WGRX N/A
- Revenue
- ACRV N/A
- WGRX $36,738,599.00
- Revenue This Year
- ACRV N/A
- WGRX N/A
- Revenue Next Year
- ACRV $805.34
- WGRX N/A
- P/E Ratio
- ACRV N/A
- WGRX N/A
- Revenue Growth
- ACRV N/A
- WGRX 82384.51
- 52 Week Low
- ACRV $1.05
- WGRX $0.34
- 52 Week High
- ACRV $8.74
- WGRX $7.04
- Technical
- Relative Strength Index (RSI)
- ACRV 48.13
- WGRX 46.51
- Support Level
- ACRV $1.91
- WGRX $0.61
- Resistance Level
- ACRV $2.46
- WGRX $0.70
- Average True Range (ATR)
- ACRV 0.17
- WGRX 0.13
- MACD
- ACRV -0.02
- WGRX 0.02
- Stochastic Oscillator
- ACRV 15.69
- WGRX 26.54
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About WGRX Wellgistics Health Inc. Common Stock
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. It is focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.